Skip to main content

Myelodysplastic Syndrome

Rare

Blood Disorders

Myelodysplastic Syndrome is treated with 8 medications in our database, including Revlimid, AZACITIDINE, Decitabine, DECITABINE, Azacitidine, and 3 more. 8 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Bristol Myers Squibb, Pilnova Pharma Inc, BluePoint Laboratories, Eisai, Celgene and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Myelodysplastic Syndrome treatment below.

What help exists for Myelodysplastic Syndrome

13

drugs indexed

6

with copay cards

6

with patient assistance

8

open travel grants

Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.

Drugs used to treat Myelodysplastic Syndrome

13 total

🎟 = copay card Β· πŸ’™ = patient assistance program

Prior authorization patterns for Myelodysplastic Syndrome drugs

Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.

PayerPAStep therapyCopay tier

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

β€”

Medicare Part D

β€”β€”β€”

Showing 10 of 20 PA rules for Myelodysplastic Syndrome drugs. View individual drug pages for complete PA detail.

Grants for Myelodysplastic Syndrome patients

13 total Β· 8 open

Myelodysplastic Syndrome is a rare disease β€” more resources at UniteRare

Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.

Visit UniteRare β†’